Emergent BioSolutions Inc. (EBS) Cash Flow Annual - Discounting Cash Flows
EBS
Emergent BioSolutions Inc.
EBS (NYSE)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2001
12-31
Report Filing: 2025-05-08 2025-03-04 2024-03-08 2023-12-11 2022-02-25 2021-02-19 2020-02-25 2019-02-22 2018-02-23 2017-02-28 2016-02-29 2015-03-06 2014-03-10 2013-03-08 2012-03-09 2011-03-11 2010-03-05 2009-03-06 2008-03-10 2007-03-27 2005-12-31 2004-12-31 2022-02-24
Net Income/Starting Line -131.6 -190.6 -760.5 -223.8 230.9 305.1 54.5 62.7 82.59 51.78 62.87 36.74 30.26 18.14 16.11 47.18 26.55 20.68 22.94 22.79 15.78 11.47 230.9
Cash From Operating Activities 110.1 58.7 -206.3 -34.1 321.1 536 188 41.8 208.1 53.49 44.46 112.3 96.97 39.64 14.59 99.54 30.51 7.32 55.45 -4.06 42.25 9.2 321.1
Depreciation and Amortization 107.2 108.8 125.1 143.3 123.8 114.5 110.7 62.2 42.57 38.23 35.34 32.45 18.96 11.2 9.36 5.99 5 4.96 4.82 4.71 3.55 1.87 123.8
Deferred Income Tax 25.3 -5.5 -8.9 -19 46.9 -2.4 -1.6 8.6 3.26 5.19 3.46 16.49 13.86 3.38 20.19 10.93 7.6 2.01 5.59 0.987 -10.97 -0.418 46.9
Stock Based Compensation 13.6 18 23.1 45.1 42.4 51.8 26.7 23.2 15.21 18.48 15.85 12.83 11.24 11.12 10.74 7.06 5.01 2.51 0 0.723 0 0 42.4
Other Non-Cash Items 88.4 39.3 485.2 19.8 33.5 59 37.6 4.2 10.78 -14.73 -7.15 0.261 -1.49 8.64 4.68 6.51 12.75 -1.47 -3.46 -0.285 -0.017 0.491 -28.2
Changes in Working Capital 186.2 88.7 -70.3 0.5 -156.4 8.8 -39.9 -119.1 53.72 -45.45 -65.9 13.54 24.14 -12.83 -46.48 21.87 -26.4 -21.37 25.54 -32.99 7.29 -4.46 -94.7
Accounts Receivable -47.7 -24.4 -21.6 114.7 -48.2 49 -8.2 -94.2 -4.81 -22.45 -64.35 21.41 35.46 -21.89 -34.87 19.09 -30.02 -6.04 0 -40.8 0 0 -48.2
Inventory -22.2 -24.5 0.6 -51.9 -44 -83.2 -16.7 -1.9 6.07 -9.03 -11.26 4.23 0.518 -0.5 -1.94 0.799 6.21 -2.83 7.83 -8.28 -3.19 -1.61 -44
Accounts Payable -36 -33 10.6 -14 -2.5 19.8 16.5 -7 16.13 -14.79 4.75 -9.28 -0.551 0.274 2.51 3.62 -1.33 -0.457 0 5.8 0 0 -2.5
Deferred Revenue 211.2 170.6 -59.9 -48.3 -61.7 23.2 -31.5 -16 36.33 0.813 4.96 -2.81 -11.28 9.28 -12.18 -1.65 -1.25 -12.05 17.72 10.29 10.48 -2.85 94.7
Other Working Capital 80.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -94.7
Cash From Investing Activities 195.5 125.2 212.3 -381.3 -225 -151 -96.9 -897.2 -249.9 -76.26 -45.46 -210.1 -67.89 -40.11 -53.96 -23.46 -33.29 -30.81 -43.97 -41.64 -5.84 -18.18 -225
Investments in Property Plant and Equipment -15.7 -22.9 -51.6 -115.8 -225 -141 -86.9 -72.1 -54.83 -76.26 -44.81 -30.67 -42.02 -53.84 -54.03 -22.1 -33.29 -20.81 -43.97 -41.23 -6.53 -17.07 -225
Payments for Acquisitions 0 0 270.2 0 0 0 0 -827.7 -195.1 0 -0.65 -179.4 -25.87 0 0 -17.87 0 0 0 -0.218 -0.559 0 0
Purchases of Securities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -4.19 -16.52 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 1.97 4.25 16.52 0 0 0 0 0 0.147 0
Other Investing Activities 211.2 148.1 -6.3 -265.5 0 -10 -10 2.6 -195.1 0 0 0 -67.89 11.77 0 16.52 0 -10 -43.97 -0.192 1.25 -1.25 0
Cash From Financing Activities -231.1 -190 -535.7 481.2 -141 69.5 -35.9 788.7 -51.4 -18.64 33.45 198.9 8.61 -1.76 14.25 -9.36 14.84 8.97 18.49 86.02 -6.66 8.68 -141
Debt Repayment -245.4 -198.4 -543.4 564.2 -35.9 62.9 13.7 795.2 -20 0 2 180.6 -0.774 3.32 12.03 -18.29 8.54 -0.751 15.03 30.86 -0.956 11.76 0
Common Stock Issued 10 9.3 8.4 0 0 31.6 8.2 0 0 17.12 0 0 0 0 10.03 7.24 4.46 3.39 2.47 54.82 0.033 0.012 0
Common Stock Repurchased -0.2 0 0 -82.1 -106 -13.8 -7.4 -0.1 -33.1 -1.1 -0.1 -0.2 -0.213 -5.91 0 61.2 0 0 0 -0.192 -0.337 -0.665 -106
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -5.4 0 0
Other Financing Activities 4.2 -1.2 -0.7 -0.9 0.9 6.6 -49.6 -6.4 1.7 -18.64 31.55 18.49 9.6 0.821 2.22 1.7 1.84 6.33 0.995 0.532 0 -2.42 -141
Effect of Forex Changes on Cash -0.7 0 -1.2 0.5 -0.3 -1 0.4 -0.2 -0.027 0.129 -0.15 0.021 -0.014 0.001 0.001 -0.634 -0.617 0.271 -0.657 -0.197 -0.276 0 -0.3
Net Change in Cash 81.8 -6.1 -530.9 66.3 -45.2 453.5 55.6 -66.9 -93.22 -41.28 32.3 101.2 37.67 -2.23 -25.12 66.09 11.45 -14.26 29.31 40.12 29.47 -0.298 -45.2
Cash at Beginning of Period 71 111.7 642.6 576.3 621.5 168 112.4 179.3 271.5 312.8 280.5 179.3 141.7 143.9 169 102.9 91.47 105.7 76.42 36.29 6.82 7.12 621.5
Cash at End of Period 152.8 105.6 111.7 642.6 576.3 621.5 168 112.4 178.3 271.5 312.8 280.5 179.3 141.7 143.9 169 102.9 91.47 105.7 76.42 36.29 6.82 576.3
Free Cash Flow 94.4 35.8 -257.9 -149.9 96.1 395 101.1 -30.3 153.3 -22.77 -0.353 81.64 54.95 -14.2 -39.43 77.44 -2.78 -13.5 11.48 -45.29 35.72 -7.88 96.1
Operating Cash Flow 110.1 58.7 -206.3 -34.1 321.1 536 188 41.8 208.1 53.49 44.46 112.3 96.97 39.64 14.59 99.54 30.51 7.32 55.45 -4.06 42.25 9.2 321.1
Capital Expenditure -15.7 -22.9 -51.6 -115.8 -225 -141 -86.9 -72.1 -54.83 -76.26 -44.81 -30.67 -42.02 -53.84 -54.03 -22.1 -33.29 -20.81 -43.97 -41.23 -6.53 -17.07 -225
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us